Actively Recruiting

Phase 1
Age: 18Years - 65Years
All Genders
Healthy Volunteers
NCT07514260

A Study to Assess Adverse Events, Tolerability, and Pharmacokinetics of Subcutaneous Injections of ABBV-295 in Healthy Adult Japanese Participants With Overweight or Obesity.

Led by AbbVie · Updated on 2026-04-15

24

Participants Needed

1

Research Sites

39 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The purpose of this study is to assess the adverse events, tolerability, and Pharmacokinetics (PK) of subcutaneous injections of ABBV-295 in healthy adult Japanese participants with overweight or obesity.

CONDITIONS

Official Title

A Study to Assess Adverse Events, Tolerability, and Pharmacokinetics of Subcutaneous Injections of ABBV-295 in Healthy Adult Japanese Participants With Overweight or Obesity.

Who Can Participate

Age: 18Years - 65Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Japanese participant must be first-or second-generation Japanese of full Japanese parentage.
  • First-generation participants must have been born in Japan to two parents and four grandparents also born in Japan of full Japanese descent.
  • Second-generation participants born outside of Japan must have two parents and four grandparents born in Japan of full Japanese descent.
  • BMI is 63; 23.0 to 63; 35.0 kg/m2 after rounding to the tenths decimal at Screening.
Not Eligible

You will not qualify if you...

  • Participant has a self-reported change in body weight 63; 5% within 3 months prior to Screening.
  • HbA1c 63; 6.5% and/or serum glucose 63; 126 mg/dL at Screening.
  • Participant has taken a medication for the purpose of treating obesity or has been enrolled in an obesity trial within 180 days prior to study treatment administration.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

CenExel ACT- Anaheim Clinical Trials /ID# 280879

Anaheim, California, United States, 92801

Actively Recruiting

Loading map...

Research Team

A

ABBVIE CALL CENTER

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

BASIC_SCIENCE

Number of Arms

4

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

A Study to Assess Adverse Events, Tolerability, and Pharmacokinetics of Subcutaneous Injections of ABBV-295 in Healthy Adult Japanese Participants With Overweight or Obesity. | DecenTrialz